2 completed, 2 recruiting, 1 suspended. 5 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 2, Suspended 1 |
| Phase 2 | 4 | Recruiting 2, Completed 1, Suspended 1 |
Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| D-serine AudRem: R33 Phase D-serine, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Suspended | New York State Psychiatric Institute | 60 | 2022-12-01 | 2026-04-29 |
| Acetazolamide for Treatment Resistant Schizophrenia Acetazolamide, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Recruiting | Vishwajit Nimgaonkar, MD PhD | 60 | 2022-02-01 | 2026-07-07 |
| Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia Cromoglycate, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Recruiting | Vishwajit Nimgaonkar, MD PhD | 160 | 2019-04-01 | 2026-03-19 |
| D-serine Augmentation of Neuroplasticity D-serine, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Completed | New York State Psychiatric Institute | 45 | 2019-03-13 | 2022-06-14 |
| A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients LY03010, Invega Sustenna 156 MG in 1 ML Prefilled Syringe - Schizo Affective Disorder, Schizophrenia | Phase 1 | Completed | Luye Pharma Group Ltd. | 48 | 2018-12-12 | 2019-08-13 |
Psychotic Disorders (5) · Schizophrenia (5)
Mental Disorders (5) · Schizophrenia Spectrum and Other Psychotic Disorders (5)
Acetazolamide (1) · Cromolyn Sodium (1) · Paliperidone Palmitate (1)
New York State Psychiatric Institute (2) · Vishwajit Nimgaonkar, MD PhD (2) · Luye Pharma Group Ltd. (1)
United States (5) · India (1)
Amy Sun, MD PhD (1) · Vishwajit L Nimgaonkar, M.D., Ph.D. (1) · Vishwajit L. Nimgaonkar, M.D., Ph.D. (1)